| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V V Tiguntsev, V I Gerasimova, E G Kornetova, O Yu Fedorenko, A N Kornetov, A A Goncharova, E G Poltavskaya, A S Boyk. [Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics]. Molekuliarnaia biologiia. vol 57. issue 1. 2023-03-28. PMID:36976738. |
we formulated a hypothesis that polymorphic variants of the grin2a, grm3, and grm7 genes may be associated with the development of hyperprolactinemia in patients with schizophrenia taking conventional and atypical antipsychotics as basic treatment. |
2023-03-28 |
2023-08-14 |
Not clear |
| V V Tiguntsev, V I Gerasimova, E G Kornetova, O Yu Fedorenko, A N Kornetov, A A Goncharova, E G Poltavskaya, A S Boyk. [Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics]. Molekuliarnaia biologiia. vol 57. issue 1. 2023-03-28. PMID:36976738. |
an association of polymorphic variants of the grin2a, grm3, and grm7 genes with the development of hyperprolactinemia in patients with schizophrenia taking conventional and atypical antipsychotics has been established for the first time. |
2023-03-28 |
2023-08-14 |
Not clear |
| V V Tiguntsev, V I Gerasimova, E G Kornetova, O Yu Fedorenko, A N Kornetov, A A Goncharova, E G Poltavskaya, A S Boyk. [Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics]. Molekuliarnaia biologiia. vol 57. issue 1. 2023-03-28. PMID:36976738. |
the identified associations of polymorphic variants of the grin2a, grm3 and grm7 genes with the development of hyperprolactinemia in patients with schizophrenia taking conventional and atypical antipsychotics have been established for the first time. |
2023-03-28 |
2023-08-14 |
Not clear |
| Izabela Fulone, Marcus Tolentino Silva, Luciane Cruz Lope. Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017. Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil. vol 32. issue 1. 2023-03-22. PMID:36946832. |
use of atypical antipsychotics in the treatment of schizophrenia in the brazilian national health system: a cohort study, 2008-2017. to investigate sociodemographic and clinical characteristics of users of atypical antipsychotics receiving care via the specialized component of pharmaceutical assistance (componente especializado da assistência farmacêutica - ceaf), for the treatment of schizophrenia in brazil, between 2008 and 2017. |
2023-03-22 |
2023-08-14 |
Not clear |
| Bram W C Storosum, Cedrine Steinz, Sem E Cohen, Taina Mattila, Wim van den Brink, Kit Roes, Lieuwe de Haan, Damiaan A J P Denys, Jasper B Zantvoor. Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board. BJPsych open. vol 9. issue 2. 2023-03-02. PMID:36861144. |
ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the dutch medicines evaluation board. |
2023-03-02 |
2023-08-14 |
Not clear |
| Moses Kule, Mark Mohan Kaggw. Adherence to Typical Antipsychotics among Patients with Schizophrenia in Uganda: A Cross-Sectional Study. Schizophrenia research and treatment. vol 2023. 2023-02-13. PMID:36778520. |
there has been a recent transition from typical to atypical antipsychotics in managing schizophrenia. |
2023-02-13 |
2023-08-14 |
Not clear |
| Ahmed M Abdelfattah, Sally A Abuelezz, Nevien Hendawy, Eman A Negm, Salwa Abd El Khalek Nawishy, Ahmed Mohamed Mohamed Khali. Sonic hedgehog pathway as a new target of atypical antipsychotics: Revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. Life sciences. 2023-01-17. PMID:36649751. |
sonic hedgehog pathway as a new target of atypical antipsychotics: revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia. |
2023-01-17 |
2023-08-14 |
rat |
| Laura Morrison, Dee Lin, Carmela Benson, Isabelle Ghelerter, Maude Vermette-Laforme, Patrick Lefebvre, Dominic Pilo. Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitate. Journal of managed care & specialty pharmacy. 2022-11-10. PMID:36354209. |
projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitate. |
2022-11-10 |
2023-08-14 |
Not clear |
| Jolanta Orzelska-Górka, Joanna Mikulska, Anna Wiszniewska, Grażyna Biał. New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. International journal of molecular sciences. vol 23. issue 18. 2022-09-23. PMID:36142523. |
new atypical antipsychotics in the treatment of schizophrenia and depression. |
2022-09-23 |
2023-08-14 |
Not clear |
| Kaoru Noda, Takehiro Kato, Nao Nomura, Mayu Sakai, Sodai Kubota, Tokuyuki Hirose, Yanyan Liu, Yoshihiro Takahashi, Ken Takao, Masami Mizuno, Takuo Hirota, Tetsuya Suwa, Yukio Horikawa, Daisuke Yab. Semaglutide is effective in type 2 diabetes and obesity with schizophrenia. Diabetology international. vol 13. issue 4. 2022-09-19. PMID:36117924. |
prevention and treatment of type 2 diabetes and obesity are problematic for individuals with schizophrenia partly because atypical antipsychotics and mental distress themselves increase appetite, thus promoting subsequent body weight gain and deterioration of glycemic control. |
2022-09-19 |
2023-08-14 |
Not clear |
| Aditi Kadakia, Brenna L Brady, Carole Dembek, G Rhys Williams, Justine M Ken. Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics. The American journal of managed care. vol 28. issue 9. 2022-09-19. PMID:36121363. |
burden of eps in commercial patients with schizophrenia initiating atypical antipsychotics. |
2022-09-19 |
2023-08-14 |
Not clear |
| Aditi Kadakia, Brenna L Brady, Carole Dembek, G Rhys Williams, Justine M Ken. Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics. The American journal of managed care. vol 28. issue 9. 2022-09-19. PMID:36121363. |
this study examined the incidence and economic burden of eps in patients with schizophrenia initiating atypical antipsychotics (aaps). |
2022-09-19 |
2023-08-14 |
Not clear |
| Carlos Fernández-Pereira, Maria Aránzazu Penedo, Tania Rivera-Baltanas, Rafael Fernández-Martínez, Saida Ortolano, José Manuel Olivares, Roberto Carlos Agís-Balbo. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients. International journal of molecular sciences. vol 23. issue 17. 2022-09-09. PMID:36076984. |
insulin-like growth factor 2 (igf-2) and insulin-like growth factor binding protein 7 (igfbp-7) are upregulated after atypical antipsychotics in spanish schizophrenia patients. |
2022-09-09 |
2023-08-14 |
Not clear |
| Fiammetta Iannuzzo, Gianpaolo Antonio Basile, Domenica Campolo, Giovanni Genovese, Gianluca Pandolfo, Loretta Giunta, Domenica Ruggeri, Antonino Di Benedetto, Antonio Brun. Metabolic and clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study. Current research in pharmacology and drug discovery. vol 3. 2022-08-22. PMID:35992380. |
alpha-lipoic acid (ala) was proposed as a new approach in schizophrenia to improve metabolic effects of atypical antipsychotics. |
2022-08-22 |
2023-08-14 |
human |
| Akitoyo Hishimoto, Norio Yasui-Furukori, Daisuke Sekine, Miyuki Matsukawa, Sakiko Yamad. Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study. Advances in therapy. 2022-07-29. PMID:35904721. |
treatment discontinuation among patients with schizophrenia treated with brexpiprazole and other oral atypical antipsychotics in japan: a retrospective observational study. |
2022-07-29 |
2023-08-14 |
Not clear |
| Akitoyo Hishimoto, Norio Yasui-Furukori, Daisuke Sekine, Miyuki Matsukawa, Sakiko Yamad. Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study. Advances in therapy. 2022-07-29. PMID:35904721. |
the aim of this exploratory study was to compare the time to treatment discontinuation between patients with schizophrenia prescribed brexpiprazole (brx group) and those prescribed other atypical antipsychotics (oaa group) in clinical settings in japan using health insurance claims data. |
2022-07-29 |
2023-08-14 |
Not clear |
| Hannah W Haddad, Elena Boardman, Brooke Williams, Rama Mouhaffel, Adam M Kaye, Alan D Kay. Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review. Health psychology research. vol 10. issue 3. 2022-07-01. PMID:35774916. |
to date, olanzapine is one of the most efficacious atypical antipsychotics (aaps) for the treatment of both schizophrenia and b1d and is associated with fewer extrapyramidal effects compared to other treatments. |
2022-07-01 |
2023-08-14 |
Not clear |
| Kouji Fukuyama, Eishi Motomura, Motohiro Okad. Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems. International journal of molecular sciences. vol 23. issue 12. 2022-06-24. PMID:35743014. |
recent pharmacodynamic studies suggested that tripartite synaptic transmission can contribute to the pathophysiology of schizophrenia and mood disorders, their associated cognitive impairment, and several adverse reactions to atypical antipsychotics. |
2022-06-24 |
2023-08-14 |
rat |
| Dandan Wang, Ning Wei, Fangzhen Hu, Jianhua Li, Yucheng Wang, Zhiwei Qian, Miao Yang, Mingrong Yao, Yong Xia, Hong Yu, Wenzhen Tu, Minjie Ye, Cheng Qian, Jianbo Hu, Jingkai Chen, Chanchan Hu, Manli Huang, Yi Xu, Shaohua H. Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study. Journal of clinical psychopharmacology. 2022-06-13. PMID:35695720. |
paliperidone is an atypical antipsychotic as effective as other atypical antipsychotics for schizophrenia. |
2022-06-13 |
2023-08-14 |
Not clear |
| Ammara Saleem, Qurat-Ul-Ain, Muhammad Furqan Akhta. Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia. Frontiers in pharmacology. vol 13. 2022-06-03. PMID:35656298. |
management of schizophrenia is usually carried out with typical and atypical antipsychotics, but it yields modest benefits with a diversity of side effects. |
2022-06-03 |
2023-08-14 |
Not clear |